From: A 4-gene signature predicts prognosis of uterine serous carcinoma
Parameters | Â | TCGA set | Training set | Testing set | P-value |
---|---|---|---|---|---|
 |  | n = 110 | n = 56 | n = 74 |  |
Age, years(mean ± SD) |  | 68.6 ± 1.6 | 66.8 ± 2.0 | 67.8 ± 2.0 | 0.395b |
Myometrium invasion, percentage (mean ± SD) | 50.1 ± 7.3 | 50.2 ± 10.1 | 49.3 ± 8.2 | 0.985b | |
Stage, no(%) | Early (I + II) | 53 (48.2) | 26 (46.4) | 32 (43.2) | 0.805 c |
 | Late (III + IV) | 57 (51.8) | 30 (53.6) | 42 (56.8) |  |
Lymph node metastasis, no(%) | YES | 34 (38.6)a | 18 (39.1) a | 31 (41.9) a | 0.908 c |
 | NO | 54 (61.4) a | 28 (60.9) a | 43 (58.1) a |  |
Vital status, no(%) | Alive | 74 (67.3) | 40 (71.4) | 48 (64.9) | 0.729 c |
 | Dead | 36 (32.7) | 16 (28.6) | 26 (35.1) |  |